Einstein/Montefiore Department of Medicine

Grand Rounds

Advances in the Treatment of NSCLC: From Zebras to Inhalational Therapy

Einstein/Montefiore Department of Medicine Grand Rounds

Thursday, September 12, 2013

8:00 AM: Forchheimer Medical Science Building 3rd Floor Lecture Hall

Speaker & Info

Bilal Piperdi, MD
Associate Professor of Clinical Medicine
Director, Thoracic Medical Oncology Program
Montefiore Einstein Center for Cancer Care

Repeated at 12:15 pm, Cherkasky Auditorium, Montefiore Medical Center.

Dr. Bilal Piperdi's research focuses on the use of novel targeted therapies in the treatment of lung and gastrointestinal malignancies. His past and current research focuses on translating early preclinical findings to clinical studies and understanding the molecular insight of clinical findings. His interest also includes managing side effects from targeted therapies. He has published several papers on preemptive treatment to mitigate side effects from epidermal growth factor inhibitors. He is currently engaged in several clinical trials and serves as Steering Committee member on some of these trials.

In addition to several book chapters, Dr. Piperdi has authored or co- authored numerous articles and abstracts in journals and presented at meetings across the world. He also serves as an ad hoc reviewer to several journals including Journal of the National Cancer Institute, Molecular Cancer Therapeutics, Cancer Chemotherapy and Pharmacology, and Cancer Epidemiology and Prevention. He is a member of American College of Physicians, the American Society of Clinical Oncology, International Association for the Study of Lung Cancer and ECOG-ACRIN Thoracic Core Committee.

Dr. Piperdi is Associate Professor of Clinical Medicine at Einstein/Montefiore. He also serves as the Director of Thoracic Medical Oncology Program and the Director of the Cancer Clinical Trials Office (CPDMU) at Montefiore Einstein Center for Cancer Care. After receiving his medical degree and early training from Hacettepe University in Ankara, Turkey, Dr. Piperdi completed a residency in internal medicine at SUNY- Upstate Medical Center and later a fellowship in Medical Oncology and Hematology at Montefiore Medical Center. After his fellowship training, he joined the University of Massachusetts Medical School as an Assistant Professor of Medicine in the Department of Hematology-Oncology. He returned to Montefiore in his current position in 2011.

After attending this activity, participants will be able to:

  1. Describe how tumor histology and molecular marker information can be utilized in clinical decision-making process regarding treatment of patients with advanced NSCLC
  2. Examine methods by which guideline recommendations concerning molecular marker testing can be reasonably implemented into clinical practice
  3. Describe the mechanisms of resistance to inhibition of molecular pathways and efforts to overcome the innate and acquired resistance

Accreditation: Albert Einstein College of Medicine designates this educational activity for a maximum of 1 credit towards the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity.

Host: Department of Medicine (Division of Oncology)

Contact Us

Department of Medicine
Albert Einstein College of Medicine
Jack and Pearl Resnick Campus
Belfer Building - Room 1008
1300 Morris Park Avenue
Bronx, NY 10461 (directions)

718.430.2591
Fax: 718.430.8563

 
Click here to log in